Open AccessTrousseau’s Syndrome Anticipating Lung Adenocarcinoma: A Combination of Novel Direct Oral Anticoagulant and Osimertinib to Treat It
Author(s) -
Irene Pecora,
Carmelo Tibaldi,
Elisabetta Perrone,
Laura Bassani,
Editta Baldini
Publication year - 2021
Language(s) - English
DOI - 10.47733/gjccr.2020.2105
Subject(s) - osimertinib , medicine , adenocarcinoma , lung , oral anticoagulant , anticoagulant , cancer , atrial fibrillation , warfarin , ros1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom